Exactly. It was a big announcement when Donohoe was retained, but no word since then. Uplisting to NASDAQ is what Donohoe does. Maybe their was some hair on the application after all. Without straight communication, we have no idea. There may or may not be a problem. We don't know. Without a value assigned to NGIO, we really have no way imminent way to experience a return on our investment.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links